Funding

National Institutes of Health (NIH) U24 Regional Comprehensive Metabolomics Core

Mayo Clinic is one of six federally funded Regional Comprehensive Metabolomics Resource Cores (RCMRCs) to support medical research using metabolomics — the study of how molecules are metabolized at the cellular level. The purpose of the RCMRC program is to facilitate institutional development of pioneering research, metabolomics training and outreach programs in this emerging area.

The supporting grant (U24DK100469) is coordinated by the National Institute of Diabetes and Digestive and Kidney Diseases, but originates from the NIH Director's Common Fund.

K Sreekumaran Nair, M.D., Ph.D., Endocrinology, is principal investigator of the U24 grant. Ian R. Lanza, Ph.D., Endocrinology, is the program coordinator and director of the Mayo Clinic Metabolomics Core.

Acknowledgment

National Institutes of Health (NIH) Public Access Policy requires that all publication that results from NIH funding be uploaded to PubMed Central. Review the process for uploading publications.

All users of the core must cite the Mayo Clinic Metabolomics Resource Core grant as a funding source in any resulting publications. Use this language:

This publication was made possible by Mayo Clinic Metabolomics Resource Core through grant number U24DK100469 from the National Institute of Diabetes and Digestive and Kidney Diseases and originates from the National Institutes of Health Director's Common Fund.